1. Home
  2. TRC vs FENC Comparison

TRC vs FENC Comparison

Compare TRC & FENC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tejon Ranch Co

TRC

Tejon Ranch Co

SELL

Current Price

$17.11

Market Cap

433.4M

Sector

Finance

ML Signal

SELL

Logo Fennec Pharmaceuticals Inc.

FENC

Fennec Pharmaceuticals Inc.

SELL

Current Price

$13.33

Market Cap

366.8M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
TRC
FENC
Founded
1843
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
433.4M
366.8M
IPO Year
1995
2010

Fundamental Metrics

Financial Performance
Metric
TRC
FENC
Price
$17.11
$13.33
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
★ $17.40
AVG Volume (30 Days)
123.5K
★ 215.3K
Earning Date
11-05-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ 0.22
0.19
Revenue
$37,830,000.00
★ $44,642,000.00
Revenue This Year
$10.83
$67.26
Revenue Next Year
N/A
$42.94
P/E Ratio
$77.73
★ $71.37
Revenue Growth
N/A
★ N/A
52 Week Low
$15.31
$5.65
52 Week High
$21.31
$13.64

Technical Indicators

Market Signals
Indicator
TRC
FENC
Relative Strength Index (RSI) 52.72 72.74
Support Level $15.87 $9.58
Resistance Level $19.78 N/A
Average True Range (ATR) 0.53 0.89
MACD 0.02 0.33
Stochastic Oscillator 47.50 98.20

Price Performance

Historical Comparison
TRC
FENC

About TRC Tejon Ranch Co

Tejon Ranch Co is a diversified real estate development and agribusiness company. It has six reporting segments: Real Estate - Commercial/Industrial, Multifamily, Real Estate - Resort/Residential, Mineral Resources, Farming, and Ranch Operations.

About FENC Fennec Pharmaceuticals Inc.

Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.

Share on Social Networks: